More prospective clinical studies as well as the detection of all KIR subtypes and second-generation gene sequencing of NK cells in ANKL are needed to obtain a better understanding of the pathogenesis of this disease. The gene discussed is KIR3DL1; the disease is aggressive NK-cell leukemia.